Rankings
▼
Calendar
STAA (STAAR Surgical Company) Stock Financials & Earnings | Market Cap Arena
STAA
STAAR Surgical Company
Mkt Cap
$860M
Healthcare
·
Medical - Instruments & Supplies
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$239M
Net Income (TTM)
-$80M
EPS (TTM)
-$1.62
Free Cash Flow (TTM)
-$34M
Gross Margin
76.2%
Op. Margin
-38.3%
Net Margin
-33.6%
FCF Margin
-14.4%
P/S Ratio (TTM)
3.6x
P/E Ratio (TTM)
—
YoY Rev Growth
-23.7%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$74M
$58M
$3M
Q2 23
$92M
$71M
$9M
Q3 23
$80M
$64M
$6M
Q4 23
$76M
$61M
$10M
Q1 24
$77M
$61M
-$2M
Q2 24
$99M
$78M
$12M
Q3 24
$89M
$68M
$6M
Q4 24
$49M
$32M
-$28M
Q1 25
$43M
$28M
-$57M
Q2 25
$44M
$33M
-$30M
Q3 25
$95M
$78M
$18M
Q4 25
$58M
$44M
-$23M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
2.9x
27.0x
Q2 23
2.8x
34.6x
Q3 23
2.8x
44.2x
Q4 23
2.7x
40.3x
Q1 24
2.6x
56.2x
Q2 24
2.6x
51.8x
Q3 24
2.5x
39.5x
Q4 24
2.7x
—
Q1 25
3.1x
—
Q2 25
3.8x
—
Q3 25
3.7x
—
Q4 25
3.6x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$5M
-$8M
Q2 23
-$6M
-$9M
Q3 23
-$6M
-$15M
Q4 23
$32M
$29M
Q1 24
$22M
$16M
Q2 24
-$10M
-$17M
Q3 24
$4M
$15M
Q4 24
$642K
-$5M
Q1 25
-$6M
-$7M
Q2 25
-$27M
-$29M
Q3 25
$3M
$2M
Q4 25
-$4K
-$4K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$3M
Q2 23
$3M
Q3 23
$9M
Q4 23
$3M
Q1 24
$5M
Q2 24
$6M
Q3 24
$11M
Q4 24
$6M
Q1 25
$1M
Q2 25
$2M
Q3 25
$883K
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+16.3%
+38.4%
Q2 23
+13.8%
+30.6%
Q3 23
+5.6%
+18.7%
Q4 23
+19.1%
+4.4%
Q1 24
+5.2%
+12.6%
Q2 24
+7.3%
+4.1%
Q3 24
+10.3%
+12.0%
Q4 24
-35.8%
+16.7%
Q1 25
-44.9%
+25.6%
Q2 25
-55.2%
-14.7%
Q3 25
+6.9%
-8.0%
Q4 25
+18.1%
+4.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$6M
8.2%
Q2 23
$8M
9.1%
Q3 23
$9M
11.0%
Q4 23
$182K
0.2%
Q1 24
$6M
8.2%
Q2 24
$9M
9.1%
Q3 24
$7M
8.1%
Q4 24
$5M
9.5%
Q1 25
$6M
14.1%
Q2 25
$8M
17.6%
Q3 25
$8M
8.6%
Q4 25
$9K
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$10M
$18M
$26M
Q2 23
$12M
$18M
$32M
Q3 23
$11M
$19M
$27M
Q4 23
$11M
$17M
$23M
Q1 24
$13M
$23M
$27M
Q2 24
$12M
$24M
$31M
Q3 24
$14M
$22M
$27M
Q4 24
$12M
$21M
$26M
Q1 25
$14M
$24M
$25M
Q2 25
$10M
$21M
$26M
Q3 25
$9M
$21M
$23M
Q4 25
$10.2B
$20M
$28M
marketcaparena.com
Revenue Segments
Cataract Intraocular Lenses
Implantable Collamer Lenses
Other Surgical Products
Quarter
Cataract Intraocular Lenses
Implantable Collamer Lenses
Other Surgical Products
Q1 23
$1M
$71M
$1M
Q2 23
$40K
$93M
—
Q3 23
$221K
$81M
—
Q4 23
—
$75M
$2M
Q1 24
—
$77M
$205K
Q2 24
—
$99M
—
Q3 24
—
$89M
—
Q1 25
—
$41M
$1M
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$90M
$114M
$204M
Q2 23
$95M
$97M
$192M
Q3 23
$127M
$61M
$188M
Q4 23
$183M
$38M
$221M
Q1 24
$224M
$21M
$245M
Q2 24
$193M
$42M
$235M
Q3 24
$164M
$72M
$236M
Q4 24
$144M
$86M
$230M
Q1 25
$173M
$50M
$223M
Q2 25
$167M
$23M
$190M
Q3 25
$176M
$17M
$193M
Q4 25
$153M
$0
$153M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
50M
+0.2%
Q2 23
50M
+0.0%
Q3 23
49M
-0.3%
Q4 23
49M
-0.3%
Q1 24
49M
-0.7%
Q2 24
50M
+1.8%
Q3 24
50M
-0.2%
Q4 24
49M
-0.9%
Q1 25
49M
+0.2%
Q2 25
50M
+0.4%
Q3 25
50M
+0.0%
Q4 25
50M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$250K
300
FY 15
$214K
360
FY 16
$245K
336
FY 17
$257K
353
FY 18
$261K
475
FY 19
$273K
550
FY 20
$284K
575
FY 21
$286K
806
FY 22
$295K
964
FY 23
$289K
1K
FY 24
$259K
1K
FY 25
$250K
957
marketcaparena.com